{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:16:22Z","timestamp":1784715382672,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"crossref","award":["No. 18-2018-0036"],"award-info":[{"award-number":["No. 18-2018-0036"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes mellitus (DM) is a well-established risk factor for the progression of degenerative aortic stenosis (AS). However, no study has investigated the impact of glycemic control on the rate of AS progression. We aimed to assess the association between the degree of glycemic control and the AS progression, using an electronic health record-based common data model (CDM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We identified patients with mild AS (aortic valve [AV] maximal velocity [Vpeak] 2.0\u20133.0\u00a0m\/sec) or moderate AS (Vpeak 3.0\u20134.0\u00a0m\/sec) at baseline, and follow-up echocardiography performed at an interval of\u2009\u2265\u20096\u00a0months, using the CDM of a tertiary hospital database. Patients were divided into 3 groups: no DM (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,027), well-controlled DM (mean glycated hemoglobin [HbA1c]\u2009&lt;\u20097.0% during the study period;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009193), and poorly controlled DM (mean HbA1c\u2009\u2265\u20097.0% during the study period;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009144). The primary outcome was the AS progression rate, calculated as the annualized change in the Vpeak (\u25b3Vpeak\/year).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the total study population (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,364), the median age was 74 (IQR 65\u201380) years, 47% were male, the median HbA1c was 6.1% (IQR 5.6\u20136.9), and the median Vpeak was 2.5\u00a0m\/sec (IQR 2.2\u20132.9). During follow-up (median 18.4\u00a0months), 16.1% of the 1,031 patients with mild AS at baseline progressed to moderate AS, and 1.8% progressed to severe AS. Among the 333 patients with moderate AS, 36.3% progressed to severe AS. The mean HbA1c level during follow-up showed a positive relationship with the AS progression rate (\u03b2\u2009=\u20092.620; 95% confidence interval [CI] 0.732\u20134.507;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007); a 1%-unit increase in HbA1c was associated with a 27% higher risk of accelerated AS progression defined as \u25b3Vpeak\/year values\u2009&gt;\u20090.2\u00a0m\/sec\/year (adjusted OR\u2009=\u20091.267 per 1%-unit increase in HbA1c; 95% CI 1.106\u20131.453;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and HbA1c\u2009\u2265\u20097.0% was significantly associated with an accelerated AS progression (adjusted odds ratio\u2009=\u20091.524; 95% CI 1.010\u20132.285;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043). This association between the degree of glycemic control and AS progression rate was observed regardless of the baseline AS severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with mild to moderate AS, the presence of DM, as well as the degree of glycemic control, is significantly associated with accelerated AS progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-023-01403-5","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T03:02:28Z","timestamp":1688958148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of glycemic control on the progression of aortic stenosis: a single-center cohort study using a common data model"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-3924","authenticated-orcid":false,"given":"In-Chang","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachung","family":"Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyoung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonyee E.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goo-Yeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"5","key":"1403_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","volume":"66","author":"TA Pawade","year":"2015","unstructured":"Pawade TA, Newby DE, Dweck MR. Calcification in aortic stenosis: the skeleton key. J Am Coll Cardiol. 2015;66(5):561\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"1403_CR2","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","volume":"39","author":"F Peeters","year":"2018","unstructured":"Peeters F, Meex SJR, Dweck MR, Aikawa E, Crijns H, Schurgers LJ, et al. Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment. Eur Heart J. 2018;39(28):2618\u201324.","journal-title":"Eur Heart J"},{"issue":"4","key":"1403_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/1479164118820657","volume":"16","author":"M Banovic","year":"2019","unstructured":"Banovic M, Athithan L, McCann GP. Aortic stenosis and diabetes mellitus: an ominous combination. Diab Vasc Dis Res. 2019;16(4):310\u201323.","journal-title":"Diab Vasc Dis Res"},{"issue":"17","key":"1403_CR4","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","volume":"113","author":"R Katz","year":"2006","unstructured":"Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation. 2006;113(17):2113\u20139.","journal-title":"Circulation"},{"issue":"6","key":"1403_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ejechocard\/jep048","volume":"10","author":"M Kamalesh","year":"2009","unstructured":"Kamalesh M, Ng C, El Masry H, Eckert G, Sawada S. Does diabetes accelerate progression of calcific aortic stenosis? Eur J Echocardiogr. 2009;10(6):723\u20135.","journal-title":"Eur J Echocardiogr"},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","volume":"262","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Wallin A, Hakansson N, Stackelberg O, Back M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol. 2018;262:66\u201370.","journal-title":"Int J Cardiol"},{"issue":"12","key":"1403_CR7","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","volume":"69","author":"AT Yan","year":"2017","unstructured":"Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC, et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. J Am Coll Cardiol. 2017;69(12):1523\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1403_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","volume":"19","author":"M Kopytek","year":"2020","unstructured":"Kopytek M, Zabczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"1403_CR9","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e72\u2013227.","journal-title":"Circulation"},{"issue":"1","key":"1403_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39 e14.","journal-title":"J Am Soc Echocardiogr."},{"issue":"4","key":"1403_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 2016;29(4):277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"1403_CR12","doi-asserted-by":"crossref","unstructured":"Steyerberg EW. Clinical prediction models. Springer; 2019.","DOI":"10.1007\/978-3-030-16399-0"},{"key":"1403_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijmedinf.2018.05.006","volume":"116","author":"LN Sanchez-Pinto","year":"2018","unstructured":"Sanchez-Pinto LN, Venable LR, Fahrenbach J, Churpek MM. Comparison of variable selection methods for clinical predictive modeling. Int J Med Inform. 2018;116:10\u20137.","journal-title":"Int J Med Inform"},{"issue":"3","key":"1403_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s10753-011-9384-7","volume":"35","author":"J Natorska","year":"2012","unstructured":"Natorska J, Wypasek E, Grudzien G, Sobczyk D, Marek G, Filip G, et al. Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? Inflammation. 2012;35(3):834\u201340.","journal-title":"Inflammation"},{"issue":"4","key":"1403_CR15","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0735-1097(01)01484-X","volume":"38","author":"A Galante","year":"2001","unstructured":"Galante A, Pietroiusti A, Vellini M, Piccolo P, Possati G, De Bonis M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol. 2001;38(4):1078\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1403_CR16","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3390\/polym12122786","volume":"12","author":"L Ciortan","year":"2020","unstructured":"Ciortan L, Macarie RD, Cecoltan S, Vadana M, Tucureanu MM, Mihaila AC, et al. Chronic high glucose concentration induces inflammatory and remodeling changes in valvular endothelial cells and valvular interstitial cells in a gelatin methacrylate 3D model of the human aortic valve. Polymers (Basel). 2020;12(12):2786.","journal-title":"Polymers (Basel)."},{"issue":"20","key":"1403_CR17","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.116.024270","volume":"135","author":"B Choi","year":"2017","unstructured":"Choi B, Lee S, Kim SM, Lee EJ, Lee SR, Kim DH, et al. Dipeptidyl peptidase-4 induces aortic valve calcification by inhibiting insulin-like growth factor-1 signaling in valvular interstitial cells. Circulation. 2017;135(20):1935\u201350.","journal-title":"Circulation"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01403-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01403-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T03:02:48Z","timestamp":1688958168000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01403-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01403-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1173479\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of Seoul National University Bundang Hospital; given the retrospective nature of the study, the need for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest or competing interests to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}